What’s it like living with cancer? Exactly two years ago today, I was lying in a hospital bed literally across the street from lab here at UC Davis. It seems unreal in a way, but painfully real it was and still is. On November 30, 2009, I had surgery for prostate cancer. Two years ago, […]
My 2 years living with cancer, what I learned from Steve Jobs Read More »
I usually stick to science on this blog, but Friday’s events on my campus, UC Davis, compel me to take a moment to discuss what happened. I am proud of our school and to be a member of the faculty. I’m proud of our students too. I am shocked and disappointed at the events that
Unprovoked UC Davis Police Attack Peaceful Student Protestors: some perspectives Read More »
Today, an authoritative article was published in the prestigious New England Journal of Medicine (NEJM) that included some of the most comprehensive polling of attitudes in the U.S. and around the world on embryonic stem cell (ESC) or ES cell research. Their findings indicate very widespread and deep support for ESC research around the globe including in
New England Journal of Med: most Americans support ES cell research Read More »
Many of us have been discouraged by Geron decision to end their stem cell program, which included products based on human embryonic stem (ES) cells, but let’s keep some perspective on this and not give up hope. The opponents of hope want us to give up. They who have waged their own self-proclaimed war on
Perspectives on Geron ending stem cell program Read More »
Yesterday Geron announced it would be immediately stopping its stem cell research program. What does this mean? While this program has (or should I say “had”) a number of elements, at its heart was of course its hESC-based OPC drug (GRNOPC1) for spinal cord injury, which was in an FDA-approved Phase I Clinical Trial that
The day after Geron news: a realistic outlook for the stem cell field Read More »
Reportedly, Geron has decided to only focus on cancer research and for financial reasons has shut down its hESC trial for spinal cord injury. This is a very sad day for stem cell science. (Update in 2020: the firm still exists, but is working in different areas. The stock has struggled.) No more spinal cord
Bad news as Geron to quit hESC SCI trial for financial reasons Read More »
I recently did a post telling you about one of my favorite molecules, Myc, which is important not only in cancer but also in most, if not all stem cells including iPS cells. There’s a lot more to Myc and how it does it’s tricks in embryonic stem cells and iPS cells. It cannot do
More on Myc: meet the “Miz’s” in our new paper Read More »
What with the Mississippi “personhood” amendment up for a vote today and also the Vatican Adult Stem Cell Conference beginning tomorrow, I thought today was a good time for a post about adult versus embryonic stem cells. Does stem cell research have to be either/or? Adult or stem? Can’t someone be for both adult and
Key points about adult versus embryonic stem cells Read More »
What is Myc? Often when we dig a little into the science of stem cells, people get turned off by all the strange names of molecules and jargon. However, whether you are a scientist, patient, investor, reporter, etc. there are some aspects of stem cell science that are ‘musts’ to know about. For example, you
Want to understand stem cells? Then you have to know Myc Read More »
I highly recommend that you guys check out the new blog by my friend, Keri Kimler. Keri is an awesome resource about stem cell research and her blog is not surprisingly, a wonderful source of information too. You can see Keri in this video from the World Stem Cell Summit: Keri is Vice Chair of
Check out new blog about stem cells by Keri Kimler Read More »